Table 1. Patient demographics.

Patient	Age	Gender (D/R)	Primary Disease	CMV status (D/R)	HLA-A, -B (R)	HLA-A, -B (D)
LTR1	62	F/F	COPD	−/−	A2, 24; B27, 44	A3, 30; B18, 65
LTR2	41	M/M	CF	−/−	A2, 3; B7, 62	A1, 32; B8, 27
LTR3	64	F/F	COPD	+/+	A2; B27, 44	A2, 32; B13, 27
LTR4	51	F/M	IPF	−/−	A2, 3; B7, 37	A24, 30; B44, 60
LTR5	35	M/F	IPF	+/+	A2, 3; B7, 18	A11, 33; B27, 58
LTR6	29	F/F	IPF	−/+	A2, 11; B13, 35	A3; B18, 27
LTR7	45	M/M	OB	+/+	A2, 31; B35	A24, 31; B55, 62
LTR8	60	M/M	COPD	+/+	A1, 2; B8, 44	A2, 30; B7, 62
LTR9	64	M/M	COPD	−/+	A2, 24; B13, 40	A2, 31; B40, 57
LTR10	39	M/M	CF	+/−	A1, 2; B7, 27	A11, 31; B51, 55
LTR11	29	F/F	CF-Bronchiectasis	+/−	A2; B39, 44	A2402, 31; B55, 61

Abbreviations: donor (D), recipient (R), female (F), male (M), cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), idiopathic bronchiolitis obliterans (OB).